Latest Breaking News On - China alliance for rare disease - Page 1 : vimarsana.com

CANbridge doses first subject in Phase I/II Gaucher disease therapy trial

First Patient Dosed in CANbridge Pharmaceuticals CAN103 Phase 1/2 Trial for the Treatment of Gaucher Disease in China

Press release content from Business Wire. The AP news staff was not involved in its creation.

Winhealth-CARD Cooperation Boosts Rare Disease Healthy Ecosystem Construction

/PRNewswire/ -- On September 30, 2021 (Hainan-Bo'ao), Hongkong Winhealth Pharma Group (Winhealth Pharma) and the China Alliance for Rare Disease (CARD)...

Winhealth-CARD Cooperation Boosts Rare Disease Healthy Ecosystem Construction

/PRNewswire/ -- On September 30, 2021 (Hainan-Bo'ao), Hongkong Winhealth Pharma Group (Winhealth Pharma) and the China Alliance for Rare Disease (CARD)...

CANbridge Pharmaceuticals CEO, James Xue, Named as Termeer Foundation Mentor

To Provide Mentoring to Emerging Life Science Leaders in Rare Disease Support Termeer Foundation's Mission of Connecting Leaders to Catalyze New Treatments ...